Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Vicriviroc: Companies, HIV-1 background & Clinical trials

Vicriviroc, previously named SCH 417690 and SCH-D, is a pyrimidine CCR5 entry inhibitor of HIV-1. It was developed by the pharmaceutical company Schering-Plough. Merck decided to not pursue regulatory approval for use in treatment-experienced patients because the drug did not meet primary efficacy endpoints in late stage trials. Clinical trials continue…

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Vicriviroc topic overview

The analysis highlights Companies, HIV-1 background and Clinical trials as prominent areas in the source structure around Vicriviroc.

Related topics
24
Source areas
5
Connected nodes
29
Extracted relationships
55
Concept neighborhoods
16
Bridge connections
29

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

HIV-1 background · 11 topics
Overview · 7 topics
Clinical trials · 3 topics
SCH-C and vicriviroc · 2 topics
Concerns surrounding CCR5 antagonists · 1 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

HIV-1 background

SCH-C and vicriviroc

Clinical trials

Concerns surrounding CCR5 antagonists

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Vicriviroc connects Entity context

The extracted context around Vicriviroc shows recurring relationship patterns in the source. For example, Vicriviroc → Additionally, Binding, CCR5, E238, I198, It, Other, Specific, Specifically, TM3, TM5, TM6, TM7, Y108, Y251 Another extracted example is Vicriviroc → CCR5, HIV-1, However, In, QT, QTc, SAR, SCH, SCH-C, Schering-Plough, When. Use these groups to spot repeated connection types before inspecting the individual relationships.

Vicriviroc

Top relations

related to Method of action · 15
Vicriviroc → Additionally, Binding, CCR5, E238, I198, It, Other, Specific, Specifically, TM3, TM5, TM6, TM7, Y108, Y251
related to SCH-C and vicriviroc · 11
Vicriviroc → CCR5, HIV-1, However, In, QT, QTc, SAR, SCH, SCH-C, Schering-Plough, When
related to Concerns surrounding CCR5 antagonists · 10
Vicriviroc → Available, CCR5, CXCR4, HIV, HIV-1, However, In, Studies, Two, V3
related to Clinical trials · 8
Vicriviroc → Currently, HIV RNA, HIV-1, HIV-infected, II, Phase II, R5-infected, The
related to background · 5
Vicriviroc → CCR5, HIV, HIV-1, However, The
instance of · 1
Vicriviroc → CCR5 inhibitors

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

ccr5 hiv-1 gp120 coreceptor virus patients hiv trials viral cell two may however antagonists gp41 cxcr4 target one entry clinical

Vicriviroc relationships Subject–Predicate–Object triples

TTTA extracted 55 structured relationships around Vicriviroc. Examples in this analysis include vicriviroc → instance of → CCR5 inhibitors and Vicriviroc → related to background → The. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
vicrivirocinstance ofCCR5 inhibitors0.80text
as well as other entry inhibitors of HIV-1instance ofCCR5 inhibitors0.80text
inhibit the initial stages of the virus life cycle.HIV-1 entryHIV binds toinstance ofCCR5 inhibitors0.80text
fuses with the target T-cells or macrophages with the help of gp120instance ofCCR5 inhibitors0.80text
gp41instance ofCCR5 inhibitors0.80text
the only two proteins that are currently known to be exhibited on the surface of the viral envelopeinstance ofCCR5 inhibitors0.80text
Vicrivirocrelated to backgroundThe0.60section
Vicrivirocrelated to backgroundHIV0.60section
Vicrivirocrelated to backgroundHowever0.60section
Vicrivirocrelated to backgroundCCR50.60section
Vicrivirocrelated to backgroundHIV-10.60section
Vicrivirocrelated to Clinical trialsCurrently0.60section

Related concept clusters Concept neighborhoods

The concept neighborhoods around Vicriviroc bring nearby vocabulary together. In this analysis, examples include May, Group and Interactions. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • ccr5
    • Hiv-1
    • Vicriviroc
    • Antagonists
    • May
    • Gene
    • Two
    • Coreceptor
    • Entry
    • Cxcr4
    • Interactions
    • Receptors
    • Sch-c
  • hiv-1
    • Coreceptor
    • Virus
    • Cxcr4
    • Vicriviroc
    • Antagonists
    • May
    • Two
    • Also
    • Compared
    • Copies
    • Use
    • Trial
  • hiv-1 background
    • Coreceptor
    • Virus
    • Cxcr4
    • Vicriviroc
    • Antagonists
    • May
    • Two
    • Also
    • Compared
    • Copies
    • Use
    • Trial
  • concerns surrounding ccr5 antagonists
    • Hiv-1
    • Vicriviroc
    • Clinical
    • Number
    • Sch-c
    • Antagonists
    • Ccr5
    • May
    • Gene
    • Two
    • Coreceptor
    • Entry
  • sch-c and vicriviroc
    • Number
    • May
    • Group
    • Interactions
    • Compared
    • Currently
    • Trial
    • Binding
    • Binds
    • Viral
    • Gene
    • Virus
  • clinical trials
    • Clinical
    • Trials
    • Antagonists
    • Number
    • Also
    • Entry
    • Sch-c
    • Vicriviroc
    • Trial
    • Cd4
    • Group
    • Hiv
  • viral envelope
    • Cd4
    • Binds
    • Currently
    • Gp41
    • Target
    • May
    • Two
    • Gp120
    • Vicriviroc
    • Compared
    • Copies
    • Protein
  • Vicriviroc
    • May
    • Group
    • Interactions
    • Compared
    • Currently
    • Trial
    • Viral
    • Virus
    • Binds
    • Cd4
    • Copies
    • Binding

Connections between topic areas Semantic bridges

For Vicriviroc, one of the stronger structural bridges in this analysis connects Vicriviroc with HIV-1 background. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Vicriviroc — HIV-1 background · splits 18 ⟂ 12
Vicriviroc — Overview · splits 22 ⟂ 8
Vicriviroc — Clinical trials · splits 26 ⟂ 4
Vicriviroc — SCH-C and vicriviroc · splits 27 ⟂ 3

Map overview Semantic statistics

Vicriviroc

Nodes30
Edges29
Triples55
Avg. degree1.93
Density0.066667
Components1

Source & methodology

TTTA analyzes the structure around Vicriviroc to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Companies, HIV-1 background & Clinical trials, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Vicriviroc · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.